The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2024

Filed:

May. 11, 2018
Applicant:

Avellino Lab Usa, Inc., Menlo Park, CA (US);

Inventors:

Tara Moore, Ballyclare, GB;

Andrew Nesbit, Coleraine, GB;

Gene Lee, Burlingame, CA (US);

Sun-young Cho, Seoul, KR;

Larry DeDionisio, Oakland, CA;

Assignee:

Avellino Lab USA, Inc., Menlo Park, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/079 (2010.01); A61K 35/30 (2015.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61P 27/02 (2006.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01); C12N 15/85 (2006.01); C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
C12N 5/0621 (2013.01); A61K 35/30 (2013.01); A61P 27/02 (2018.01); C12N 9/22 (2013.01); C12N 15/113 (2013.01); C12N 15/85 (2013.01); C12Q 1/68 (2013.01); C12Q 1/6883 (2013.01); A61L 27/3604 (2013.01); A61L 27/3666 (2013.01); A61L 27/3695 (2013.01); A61L 27/54 (2013.01); C12N 2510/00 (2013.01); C12N 2533/92 (2013.01); C12Q 2600/156 (2013.01);
Abstract

Methods and compositions for the treatment of a corneal dystrophy in a subject in need thereof are provided. In one aspect, the method includes the step of obtaining a plurality of stem cells comprising a nucleic acid mutation in a corneal dystrophy target nucleic acid from the subject and manipulating the nucleic acid mutation in one or more stem cells of the plurality of stem cells to correct the nucleic acid mutation, thereby forming one or more manipulated stem cells. The manipulated stem cells are isolated and then transplanted into the subject. In some embodiments, the nucleic acid mutation is manipulated using CRISPR system.


Find Patent Forward Citations

Loading…